...
首页> 外文期刊>Biomedicine hub. >Design of Surfactant Protein B Peptide Mimics Based on the Saposin Fold for Synthetic Lung Surfactants
【24h】

Design of Surfactant Protein B Peptide Mimics Based on the Saposin Fold for Synthetic Lung Surfactants

机译:基于Saposin折叠的合成肺表面活性剂表面活性剂蛋白B肽模拟物的设计

获取原文

摘要

Surfactant protein (SP)-B is a 79-residue polypeptide crucial for the biophysical and physiological function of endogenous lung surfactant. SP-B is a member of the saposin or saposin-like proteins (SAPLIP) family of proteins that share an overall three-dimensional folding pattern based on secondary structures and disulfide connectivity and exhibit a wide diversity of biological functions. Here, we review the synthesis, molecular biophysics and activity of synthetic analogs of saposin proteins designed to mimic those interactions of the parent proteins with lipids that enhance interfacial activity. Saposin proteins generally interact with target lipids as either monomers or multimers via well-defined amphipathic helices, flexible hinge domains, and insertion sequences. Based on the known 3D-structural motif for the saposin family, we show how bioengineering techniques may be used to develop minimal peptide constructs that maintain desirable structural properties and activities in biomedical applications. One important application is the molecular design, synthesis and activity of Saposin mimics based on the SP-B structure. Synthetic lung surfactants containing active SP-B analogs may be potentially useful in treating diseases of surfactant deficiency or dysfunction including the neonatal respiratory distress syndrome and acute lung injury/acute respiratory distress syndrome.
机译:表面活性剂蛋白(SP)-B是对内源性肺表面活性剂的生物物理和生理功能至关重要的79个残基的多肽。 SP-B是saposin或saposin样蛋白(SAPLIP)家族的成员,它们基于二级结构和二硫键连接共享整体三维折叠模式,并具有多种生物学功能。在这里,我们审查了合成,分子生物学和saposin蛋白的合成类似物的活性,旨在模拟母体蛋白与增强界面活性的脂质的相互作用。沙波蛋白通常通过明确的两亲性螺旋,柔性铰链结构域和插入序列与目标脂质作为单体或多聚体相互作用。基于saposin家族的已知3D结构基序,我们展示了如何使用生物工程技术开发最小的肽构建体,从而在生物医学应用中保持所需的结构性质和活性。一个重要的应用是基于SP-B结构的Saposin模拟物的分子设计,合成和活性。含有活性SP-B类似物的合成肺表面活性剂可能可用于治疗表面活性剂缺乏或功能障碍的疾病,包括新生儿呼吸窘迫综合征和急性肺损伤/急性呼吸窘迫综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号